GlassScriptPhysician profile
Wynd N Counts
NPI 1922179480
$513.80
in general payments reported to CMS, 2019-2025
10 companies · $81.10 in 2025
The $81.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.67 · 2020: $18.50 · 2021: $30.44 · 2022: $72.54 · 2023: $142 · 2024: $77.31 · 2025: $81.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278 · Education: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.61 |
| Education | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $136.36 | 2019-2024 | Lo Loestrin Fe |
| Astellas Pharma US INC | $100.74 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $57.65 | 2022-2023 | Thinprep 2000 Processor |
| Pfizer INC. | $46.08 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $36.66 | 2023-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $33.91 | 2019 | |
| Sage Therapeutics, LLC | $33.60 | 2025 | Zurzuvae |
| Amgen INC. | $32.67 | 2025 | Krystexxa |
| Myovant Sciences INC. | $21.00 | 2022 | |
| Coopersurgical, INC. | $15.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wynd Counts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.